
Evidence analysis
Concerns raised over older heavy drinkers
What is established Recent public health data from the Centers for Disease Control and Prevention (CDC) indicates that alcohol consumption patterns in the United States have shifted notably in the years following the COVID-19 pandemic. While younger adults…
Read →
Evidence analysis
Human medicines European public assessment report (EPAR): Aldurazyme, laronidase, Date of authorisation: 09/06/2003, Revision: 28, Status: Authorised
What is established Aldurazyme is a medicinal enzyme replacement therapy containing the active substance laronidase. It is approved in the European Union for the treatment of mucopolysaccharidosis I (MPS I), a rare inherited metabolic disorder caused by a…
Read →
Evidence analysis
Human medicines European public assessment report (EPAR): Yorvipath, palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 6, Status: Authorised
What is established Yorvipath is a hormone replacement therapy authorized by the European Medicines Agency (EMA) for treating adults with chronic hypoparathyroidism, a rare endocrine disorder characterized by insufficient production of parathyroid hormone (PTH). The active substance in…
Read →
Evidence analysis
Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 12, Status: Authorised
Evidence Dossier: Rivaroxaban Viatris – Health & Science What is established Rivaroxaban Viatris is an anticoagulant medication authorized for use in the European Union since November 12, 2021. It contains the active substance rivaroxaban, a direct factor Xa…
Read →
Evidence analysis
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 November 2026
Evidence Dossier: Veterinary Medicinal Products Committee Meeting November 2026 What is established In November 2026, the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) held a meeting to review and adopt opinions on several veterinary medicinal products…
Read →
Evidence analysis
In Rio, A Celebration of Life
What is Established On October 28, 2025, a police operation took place in Complexo da Penha, a group of favelas in Rio de Janeiro, Brazil. During this raid, 122 people died, including two boys and five police officers,…
Read →
Evidence analysis
Civil Society Call for Scrutiny of United States’ Rights Record
Evidence Dossier: Civil Society Appeals for Scrutiny of United States’ Human Rights Record Source: Human Rights Watch News, November 6, 2026 What is established The United States is scheduled for its Universal Periodic Review (UPR) by the United…
Read →
Evidence analysis
A New Chapter for Corporate Accountability in the UK and the Road Ahead
What is established On November 4, 2026, the UK government announced plans to introduce legislation that would regulate corporate conduct regarding human rights impacts within their global supply chains. The proposed law aims to impose robust responsibilities on…
Read →
Evidence analysis
Human medicines European public assessment report (EPAR): Vabysmo, faricimab, Date of authorisation: 15/09/2022, Revision: 11, Status: Authorised
Evidence Dossier: Vabysmo (faricimab) – Treatment for Retinal Diseases What is established Vabysmo is a medicine containing the active ingredient faricimab, authorized in the European Union since September 15, 2022, for treatment of certain retinal diseases affecting adults.…
Read →
Evidence analysis
Influenza virus characteristics, week 40 2025 to week 33 2026, EU/EEA
Influenza Virus Characteristics in the EU/EEA: Summary of Surveillance Data from Week 40 2025 to Week 33 2026 What is established The European Centre for Disease Prevention and Control (ECDC), through a report produced on behalf of the…
Read →